A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS

BMC Neuroscience

Volumn 5, Issue , 2004, Pages

  Fuller, Robert A ^a   Westomoreland, Susan V ^b   Ratai, Eva ^a   Greco, Jane B ^a   Kim, John P ^a   Lentz, Margaret R ^a   He, Julian ^a   Sehgal, Prabhat K ^b   Masliah, Eliezer ^c   Halpern, Elkan ^a   Lackner, Andrew A ^d   González, R Gilberto ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BRAIN INJURY; BRAIN METABOLISM; BRAIN REGION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DYNAMICS; FEMALE; FRONTAL CORTEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IN VIVO STUDY; INOCULATION; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MACACA; MALE; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICAL SIGNIFICANCE; STEREOTYPY; VIRUS ENCEPHALITIS; VIRUS LOAD;

ACUTE DISEASE; AIDS DEMENTIA COMPLEX; ANIMALS; ASPARTIC ACID; BRAIN; CHOLINE; CHRONIC DISEASE; CREATINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; INOSITOL; LONGITUDINAL STUDIES; MACACA MULATTA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL RATE; VIRAL LOAD;

EID: 2642522995     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-5-10     Document Type: Article

References (42)

1. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, Baudouin CJ, Kocsis AE, Harris JR: Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992, 16:538-542.
2. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I: Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993, 186:739-744.
3. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G: Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993, 43:509-515.
4. Barker PB, Lee RR, McArthur JC: AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995, 195:58-64.
5. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG: Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology 1996, 46:783-788.
6. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M: HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996, 199:805-810.
7. Lopez-Villegas D, Lenkinski RE, Frank I: Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997, 94:9854-9859.
8. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G: Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999, 52:995-1003.
9. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E: Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999, 52:100-108.
10. Suwanwelaa N, Phanuphak P, Phanthumchinda K, Suwanwela NC, Tantivatana J, Ruxrungtham K, Suttipan J, Wangsuphachart S, Hanvanich M: Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging 2000, 18:859-865.
11. Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA: A multi-center 1H MRS study of the AIDS dementia complex: Validation and preliminary analysis. J Magn Reson Imaging 2003, 17:625-633.
12. McConnell JR, Swindells S, Ong CS, Gmeiner WH, Chu WK, Brown DK, Gendelman HE: Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retroviruses 1994, 10:977-982.
13. Burudi EME, Fox Howard S.: Simian Immunodeficiency Virus Model of HIV-Induced Central Nervous System Dysfunction. Adv. Virus Reaserch 2001, 56:435-468.
14. Greco JB, Sakaie KE, Aminipour S, Lee PL, Chang LL, He J, Westmoreland S, Lackner AA, Gonzalez RG: Magnetic resonance spectroscopy: an in vivo tool for monitoring cerebral injury in SIV-infected macaques. J Med Primatol 2002, 31:228-236.
15. Tracey I, Lane J, Chang I, Navia B, Lackner A, Gonzalez RG: 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:21-27.
16. Gonzalez RG, Cheng LL, Westmoreland SV, Sakaie KE, Becerra LR, Lee PL, Masliah E, Lackner AA: Early brain injury in the SIV-macaque model of AIDS. Aids 2000, 14:2841-2849.
17. Greco JB, Sakaie KE, He J, Aminipour S, Lee PL, Cheng LL, Westmoreland S, Lackner A, Gonzalez RG: In vivo detection of reversible neurochemical changes during acute SIV infection by magnetic resonance spectroscopy. J Neurovirol 2002, 8 (Suppl 1):94.
18. Westmoreland SV, Halpern E, Lackner AA: Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J Neurovirol 1998, 4:260-268.
19. Orandle MS, Williams KC, MacLean AG, Westmoreland SV, Lackner AA: Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J Virol 2001, 75:4448-4452.
20. Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, Heyes MP, Lackner AA: Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J Neurovirol 1996, 2:423-432.
21. Pelletier E, Saurin W, Cheynier R, Letvin NL, Wain-Hobson S: The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 1995, 208:644-652.
22. Burns DP, Desrosiers RC: Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol 1991, 65:1843-1854.
23. Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995, 69:5087-5094.
24. Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267:483-489.
25. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE: Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001, 184:1015-1021.
26. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M: Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol 1994, 145:428-439.
27. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IV, et al.: Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993, 188:119-124.
28. Gartner S: HIV infection and dementia. Science 2000, 287:602-604.
29. Moller HE, Vermathen P, Lentschig MG, Schuierer G, Schwarz S, Wiedermann D, Evers S, Husstedt IW: Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 1999, 9:10-18.
30. Meyerhoff DJ, MacKay S, Poole N, Dillon WP, Weiner MW, Fein G: N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 1994, 12:653-659.
31. Williams K, Schwartz A, Corey S, Orandle M, Kennedy W, Thompson B, Alvarez X, Brown C, Gartner S, Lackner A: Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am J Pathol 2002, 161:575-585.
32. Orandle MS, MacLean AG, Sasseville VG, Alvarez X, Lackner AA: Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J Virol 2002, 76:5797-5802.
33. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001, 7:528-541.
34. Kodama T, Mori K, Kawahara T, Ringler DJ, Desrosiers RC: Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol 1993, 67:6522-6534.
35. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987, 508:333-348.
36. Haase A, Frahm J, Hanicke W, Matthaei D: 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985, 30:341-344.
37. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE: Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994, 31:365-373.
38. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD: Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1998, 14:183-189.
39. Desrosiers RC, Lifson JD, Gibbs JS, Czajak SC, Howe AY, Arthur LO, Johnson RP: Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 1998, 72:1431-1437.
40. Wykrzykowska JJ, Rosenzweig M, Veazey RS, Simon MA, Halvorsen K, Desrosiers RC, Johnson RP, Lackner AA: Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 1998, 187:1767-1778.
41. Hirsch VM, Adger-Johnson D, Campbell B, Goldstein S, Brown C, Elkins W, Montefiori DC: A Molecularly Cloned Pathogenic, neutralization-resistant Simian Immunodeficiency Virus, SIVsmmE543-3. Virology 1997, 71:1608-1620.
42. Veazey RS, Tham IC, Mansfield KG, DeMaria M, Forand AE, Shvetz DE, Chalifoux LV, Sehgal PK, Lackner AA: Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000, 74:57-64.